--Amgen today announced full results from Part 1 of the Phase 2 study for MariTide in patients living with obesity, with and without Type 2 diabetes, will be presented along with new data from the ...

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type 2 ...

When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the arteries and cardiovascular health.

You recently wrote about a study regarding aspirin therapy for people with high Lp(a) levels. What is the current thinking?

Nexletol (bempedoic acid) is a prescription tablet that treats high cholesterol and reduces heart-related risks in certain adults. Learn about dosage, side effects, and more.

FDA approves single-dose monthly injector for cholesterol drug The Food and Drug Administration recently approved Amgen's Repatha Pushtronex system.

A phase II study bolstering outcomes by optimizing immunotherapy strategies with evolocumab and nivolumab in patients with metastatic renal cell carcinoma (BOOST-RCC).

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

The LIBerate-HoFH study assessed the safety and efficacy of monthly lerodalcibep and evolocumab in a randomized, cross-over trial, with 24 weeks of treatment in each period separated by a washout ...

Can your cholesterol drop too low? Drugs can now drive blood cholesterol levels lower than ever. But how low is too low?

Options for Treating Non-Familial Hypercholesterolemia — Statins, ezetimibe, PCSK9 inhibitors, bile acid sequestrants, bempedoic acid, and more ...

Most Medicare Part D and Advantage plans cover Repatha injections. Read about the cost of Repatha after paying the deductible, generic alternatives, and more.